Implantica AG (publ) announced that the RefluxStop procedure to treat acid reflux is now being successfully implemented at Spire Manchester Hospital, part of the Spire Healthcare Group.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.4 SEK | +0.37% | -5.35% | +14.64% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.64% | 706M | |
+73.16% | 12.38B | |
-19.29% | 7.61B | |
+14.06% | 7.11B | |
+4.77% | 5.83B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-19.09% | 4.02B | |
-31.59% | 2.16B | |
+1.24% | 2.01B |
- Stock Market
- Equities
- IMP A SDB Stock
- News Implantica AG
- Implantica AG Announces Spire Manchester Hospital in UK Begins Operating with RefluxStop™